Investigation of parental socioeconomic status as a determinant of dietary habits and disease severity of sickle cell disease children

  • Authors

    • Anuoluwapo Abisola Alaka Ladoke Akintola University of Technology
    • Ayobola Abolape Iyanda Adeleke University, Ede
    2024-07-13
    https://doi.org/10.14419/pshdds82
  • Disease Severity; Fruit/Vegetable Intake; Sickle Cell Disease; Socioeconomic Status.

  • Abstract

    Background: Socioeconomic status (SES) impacts dietary choices and poor dietary pattern has been reported to play a role in the etio-pathogenic mechanisms that give rise to various diseases. Objective: The study is designed to explore the relationship between parental SES and both the dietary habits and disease severity markers among sickle cell disease (SCD) pediatric patients. Methods: Participants’ hemoglobin genotypes and hematocrit levels were determined using standard methods. Questionnaire was administered to the participants to obtain information on qualitative parameters. Descriptive and inferential statistics were used for data analysis. Significant level was set with P < .05. Results: A high percentage of parents of SCD participants were of medium to high SES [73.33%- HbSC; 64.29%- HbSS]. While the rates of hospitalization of HbSS (92.85%) and HbSC (66.67%) were dissimilar, the rates of patients that had suffered vaso-occlusive crisis (VOC) in the last three months prior to the study were comparable [46.67%-HbSC; 53.57%-HbSS]. The daily fruit/vegetable consumption habits of 3 genotypes were poor ranging from 15-25%. The hematocrit levels of the 3 groups were significantly different. Conclusion: The study suggests that high percentage of patients belong to medium-high SES, signifying that educational background of parents did not impact prevalence of the disease.

  • References

    1. Inusa BPD, Hsu LL, Kohli N, Patel A, Ominu-Evbota K, et al. Sickle Cell Disease-Genetics, Pathophysiology, Clinical Presentation and Treatment. Int J Neonatal Screen. 2019 May 7;5(2):20. https://doi.org/10.3390/ijns5020020.
    2. Elendu C, Amaechi DC, Alakwe-Ojimba CE, Elendu TC, Elendu RC, et al. Understanding Sickle cell disease: Causes, symptoms, and treatment options. Medicine (Baltimore). 2023 Sep 22;102(38):e35237. https://doi.org/10.1097/MD.0000000000035237.
    3. Nkya S, Mwita L, Mgaya J, Kumburu H., Zwetselaar M, et al. Identifying genetic variants and pathways associated with extreme levels of fetal hemoglobin in sickle cell disease in Tanzania. BMC Med Genet 202; 21, 125. https://doi.org/10.1186/s12881-020-01059-1.
    4. Alaka AA, Alaka OO, Iyanda AA. Zinc and Anthropometry in Sickle Cell Disease: Comparison between Two Genotypes (SS and SC Hemoglobinopathies). J Integrated Health Sci 2022;10(2): 60-66. | https://doi.org/10.4103/jihs.jihs_6_22.
    5. Alaka AA, Alaka OO, Iyanda AA. Nitric oxide and zinc levels in sickle cell hemoglobinopathies: a relationship with the markers of dis-ease severity. Pomeranian J Life Sci [S.l.], v. 69, n. 1, mar. 2023. ISSN 2450-4637. Available at: <https://ojs.pum.edu.pl/pomjlifesci/article/view/887>. Date accessed: 29 June 2023.
    6. Iragbogie IA, Maimuna YO, Hayatu A, Dalhat AS, Musa IK. Clinical profile of paediatric sickle cell disease at a reference hospital in North– eastern Nigeria. Niger J Paediatr 2021; 48 (2):74 – 81. https://doi.org/10.4314/njp.v48i2.3.
    7. Rab MAE, van Oirschot BA, Bos J, Merkx TH, van Wesel ACW, et al. Rapid and reproducible characterization of sickling during auto-mated deoxygenation in sickle cell disease patients. Am J Hematol. 2019 May;94(5):575-584. https://doi.org/10.1002/ajh.25443.
    8. Eaton WA. Hemoglobin S polymerization and sickle cell disease: A retrospective on the occasion of the 70th anniversary of Pauling's Science paper. Am J Hematol. 2020 Feb;95(2):205-211. https://doi.org/10.1002/ajh.25687.
    9. Suhail M. Biophysical chemistry behind sickle cell anemia and the mechanism of voxelotor action. Sci Rep 14, 1861 (2024). https://doi.org/10.1038/s41598-024-52476-8.
    10. Quinn CT. Clinical severity in sickle cell disease: the challenges of definition and prognostication. Experimental Biology and Medicine 2016; 241: 679–688. https://doi.org/10.1177/1535370216640385.
    11. Jang T, Poplawska M, Cimpeanu E, Mo G, Dutta D, et al. Vaso-occlusive crisis in sickle cell disease: a vicious cycle of secondary events. J Transl Med 19, 397 (2021). https://doi.org/10.1186/s12967-021-03074-z.
    12. Odunvbun ME, Okolo AA, Rahimy CM. Newborn screening for sickle cell disease in a Nigerian hospital. Public Health 2008; 122:1111. https://doi.org/10.1016/j.puhe.2008.01.008.
    13. Anetor JI, Igharo OG, Anetor GO, Nwobi L, Iyanda AA. The Zamfara lead poisoning episode in Nigeria: an indication for children’s environmental toxicology and micronutrient centre. Toxicology Digest. 2016;1: 23-33.
    14. Iyanda AA. Serum heavy metal levels in teenagers currently or formerly employed as gas station attendants. Bangladesh J Med Sci. 2018;17(2): 224-229. https://doi.org/10.3329/bjms.v17i2.35875.
    15. Oyedeji GA. Socio-economic and cultural background of hospitalized children in llesha. Nigeria J Paed 1985;12:111–117.
    16. Snyder AB, Lakshmanan S, Hulihan MM, Hulihan MM, Paulukonis ST et al. Surveillance for Sickle Cell Disease — Sickle Cell Data Collection Program, Two States, 2004–2018. MMWR Surveill Summ 2022;71(No. SS-9):1–18. https://doi.org/10.15585/mmwr.ss7109a1.
    17. Ajeigbe KA, Adejumo O, OwojuyigbeT, Ayinbuomwan E, Okesina B, Disease severity and renal function among sickle cell anaemia patients in a tertiary hospital, South-south, Nigeria: a cross sectional study . Malawi Med J. 2023; 35 (1); 9-14 March 2023 https://doi.org/10.4314/mmj.v35i1.3.
    18. Antwi-Boasiako C, Dankwah GB, Aryee R, Hayfron-Benjamin C, Aboagye G, et al. Correlation of lipid peroxidation and nitric oxide metabolites, trace elements, and antioxidant enzymes in patients with sickle cell disease. J Clin Lab Anal. 2020 Jul;34(7):e23294. https://doi.org/10.1002/jcla.23294.
    19. Vona R, Sposi NM, Lorenza Mattia L, Gambardella L, Straface E, et al. Sickle Cell Disease: Role of Oxidative Stress and Antioxidant Therapy. Antioxidants, 2021; 10, 2: 296. https://doi.org/10.3390/antiox10020296.
    20. Lin G, Field JJ, Yu JC, Ken R, Neuberg D, et al. NF-κB is activated in CD4+ iNKT cells by sickle cell disease and mediates rapid induc-tion of adenosine A2A receptors. PLoS One. 2013 Oct 4;8(10):e74664. https://doi.org/10.1371/journal.pone.0074664.
    21. Das I, Mishra H, Khodiar PK, Patra PK. Identification of therapeutic targets for inflammation in sickle cell disease (SCD) among Indian patients using gene expression data analysis. Bioinformation. 2018 Jul 31;14(7):408-413. https://doi.org/10.6026/97320630014408.
    22. Mussbacher M, Salzmann M, Brostjan C, Hoesel B, Schoergenhofer C, et al. Cell Type-Specific Roles of NF-κB Linking Inflammation and Thrombosis. Front Immunol. 2019 Feb 4;10:85. https://doi.org/10.3389/fimmu.2019.00085.
    23. Belcher JD, Chen C, Nguyen J. The fucosylation inhibitor, 2-fluorofucose, inhibits vaso-occlusion, leukocyteendothelium interactions and NF-kB activation in transgenic sickle mice. PLoS One. 2015; 10(2):e0117772. https://doi.org/10.1371/journal.pone.0117772.
    24. Matte A, Zorzi F, Mazzi F, Federti E, Olivieri O, et al. New Therapeutic Options for the Treatment of Sickle Cell Disease. Mediterr J Hematol Infect Dis. 2019 Jan 1;11(1):e2019002. https://doi.org/10.4084/mjhid.2019.002.
    25. Matte A, Recchiuti A, Federti E, Koehl B, Mintz T, et al. Resolution of sickle cell disease-associated inflammation and tissue damage with 17R-resolvin D1. Blood. 2019 Jan 17;133(3):252-265. https://doi.org/10.1182/blood-2018-07-865378.
    26. Matte A, Cappellini MD, Iolascon, A, Enrica F, Franceschi LD. Emerging drugs in randomized controlled trials for sickle cell disease: are we on the brink of a new era in research and treatment?, Expert Opinion on Investigational Drugs. 2020;29:1, 23-31, https://doi.org/10.1080/13543784.2020.1703947.
    27. Ansari J, Gavins FNE. Ischemia-Reperfusion Injury in Sickle Cell Disease: From Basics to Therapeutics. Am J Pathol. 2019 Apr;189(4):706-718. https://doi.org/10.1016/j.ajpath.2018.12.012.
    28. Adigwe OP, Onavbavba G, Onoja SO. Impact of Sickle Cell Disease on Affected Individuals in Nigeria: A Critical Review. Int J Gen Med. 2023;16:3503-3515 https://doi.org/10.2147/IJGM.S410015.
    29. Adigwe OP. Knowledge and awareness of sickle cell disease: a cross sectional study amongst unmarried adults in Nigeria’s capital city. J Community Genet. 2022; 13:579–585. https://doi.org/10.1007/s12687-022-00607-x.
    30. John C, Poh BK, Jalaludin MY, Michael G, Adedeji I, et al. Exploring disparities in malnutrition among under-five children in Nigeria and potential solutions: a scoping review. Front Nutr. 2024 Jan 5;10:1279130. https://doi.org/10.3389/fnut.2023.1279130.
    31. Abdullahi SU, Gambo S, Murtala HA, Kabir H, Shamsu KA, et al. Feasibility trial for the management of severe acute malnutrition in older children with sickle cell anemia in Nigeria. Blood Adv. 2023 Oct 24;7(20):6024-6034. https://doi.org/10.1182/bloodadvances.2023010789.
    32. Iyanda AA. Serum elements status of androgenetic alopecia subjects exposed to cigarette smoke or alcohol. Journal of Emerging Trends in Engineering and Applied Sciences. 2012; 3(4): 702-707. United Kingdom. http://www.jeteas.scholarlinkresearch.com
    33. Iyanda AA. Serum vitamin levels in different categories of androgenetic alopecia subjects. Scientificreports 2012; 1: 137. https://doi.org/10.4172/scientificreports.137.
    34. Anetor JI, Iyanda AA, Akinseye I, Anetor GO. Strengthening analytical capability in micronutrients: A prophylactic approach to DNA repair defects, genome instability and carcinogenesis in developing countries. 5th FESTEM, Congress, Avignon, France; 2013; May 22nd -24th, 2013.
    35. He Z, Bishwajit G, Zou D, Yaya S, Cheng Z, et al. Burden of Common Childhood Diseases in Relation to Improved Water, Sanitation, and Hygiene (WASH) among Nigerian Children. Int J Environ Res Public Health 2018, 15, 1241. https://doi.org/10.3390/ijerph15061241.

  • Downloads

  • How to Cite

    Abisola Alaka , A. ., & Abolape Iyanda , A. . (2024). Investigation of parental socioeconomic status as a determinant of dietary habits and disease severity of sickle cell disease children. International Journal of Biological Research, 11(2), 45-49. https://doi.org/10.14419/pshdds82